½ÃÀ庸°í¼
»óÇ°ÄÚµå
1496878
¼¼°èÀÇ È»ó Ä¡·á ½ÃÀå(2024-2031³â)Global Burn Care Market - 2024-2031 |
¼¼°è È»ó Ä¡·á ½ÃÀåÀº 2023³â 25¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇß°í, 2031³â¿¡´Â 44¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2031³â°£ 7.4%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
È»óÀº ÁÖ·Î ¿, ¹æ»ç¼±, ¹æ»ç´É, Àü±â, ¸¶Âû, ÈÇй°Áú°úÀÇ Á¢ÃËÀ¸·Î ÀÎÇÑ ÇǺΠ¹× ±âŸ À¯±âÁ¶Á÷ÀÇ ¼Õ»óÀÔ´Ï´Ù.
È»óÀº ¾ãÀº ¿ÜÇ¥ÇÇ¿Í µÎ²®°í ±íÀº ÁøÇÇ µÎ ÃþÀ» Æ÷ÇÔÇÏ´Â ÇǺΠ¼Õ»óÀÔ´Ï´Ù. È»óÀÇ 86%´Â È»ó¿¡ ÀÇÇÑ °ÍÀ̸ç, Àü±â·Î ÀÎÇÑ È»óÀº ¾à 4%, ÈÇй°Áú·Î ÀÎÇÑ È»óÀº ¾à 3%ÀÔ´Ï´Ù.
½ÃÀåÀº È»ó ¹ß»ý·ü Áõ°¡, Ä¡·á ¹× ±â¼ú ¹ßÀü¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÇǺΠÀÌ½Ä ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
¼ºÀå ÃËÁø¿äÀÎ
È»ó ¹ß»ý·ü Áõ°¡/p>
¼¼°è È»ó Ä¡·á ½ÃÀå ¼ö¿ä´Â ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. È»óÀº ÁßÀú¼Òµæ ±¹°¡¿¡¼ ¼Õ½ÇµÇ´Â Àå¾Ö Á¶Á¤ »ýÁ¸³â¼ö(DALY)ÀÇ ÁÖ¿ä ¿øÀÎ Áß ÇϳªÀÔ´Ï´Ù.
2023³â 10¿ù WHO Åë°è¿¡ µû¸£¸é, Àεµ¿¡¼´Â ¸Å³â 100¸¸ ¸í ÀÌ»óÀÌ Áߵ ¶Ç´Â ÁßÁõ È»óÀ» ÀÔ½À´Ï´Ù. ¹æ±Û¶óµ¥½Ã¿¡¼´Â ¸Å³â ¾à 17¸¸ 3,000¸íÀÇ ¾î¸°ÀÌ°¡ Áߵ ¶Ç´Â ÁßÁõÀÇ È»óÀ» ÀÔ½À´Ï´Ù. ¹æ±Û¶óµ¥½Ã, ÄÝ·Òºñ¾Æ, ÀÌÁýÆ®, ÆÄÅ°½ºÅº¿¡¼ È»óÀ» ÀÔÀº ¾î¸°ÀÌÀÇ 17%´Â ÀϽÃÀûÀÎ Àå¾Ö¸¦, 18%´Â ¿µ±¸ÀûÀÎ Àå¾Ö¸¦ ÀÔ½À´Ï´Ù.
¶ÇÇÑ, ÆÄÆ®³Ê½Ê, Á¦ÈÞ, Á¤ºÎ À̴ϼÅƼºê, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀΰú °°Àº ÁÖ¿ä ±â¾÷ÀÇ Àü·«ÀÌ ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¿¹¸¦ µé¾î, 2023³â 6¿ù, ·ÎÅ͸®Å¬·´Àº Aster MIMS, Calicut°ú ÇÔ²² ºÏÄɶö¶ó ÁÖ ÃÖÃÊÀÇ ½ºÅ² ¹ðÅ©(Skin Bank)¸¦ ¼³¸³Çß½À´Ï´Ù. ÀÌ È¹±âÀûÀÎ À̴ϼÅƼºê´Â È»ó ȯÀÚÀÇ ÇǺΠÀ̽Ŀ¡ ´ëÇÑ Àý½ÇÇÑ Çʿ並 ÃæÁ·½ÃÅ°°í ȸº¹ °¡´É¼ºÀ» Å©°Ô Çâ»ó½ÃÅ°´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ°í ÀÖ½À´Ï´Ù.
¶ÇÇÑ 2024³â 2¿ù¿¡´Â ¶ûÅ°¿¡¼ NABICON ÄÁÆÛ·±½º°¡ °³ÃֵǾî È»ó °ü¸®ÀÇ ¹ßÀü¿¡ ´ëÇØ ³íÀÇÇÏ°í ÀÎ½Ä °³¼±°ú Ä¡·á °È¿¡ ´ëÇÑ ³íÀÇ°¡ ÀÌ·ç¾îÁú ¿¹Á¤ÀÔ´Ï´Ù.
¸¶Âù°¡Áö·Î 2023³â 9¿ù, Vericell CorporationÀº ¼ºÀÎÀÇ ±íÀº ºÎºÐ È»ó ¹×/¶Ç´Â ÀüÃþ È»ó ÈäÅÍ Á¦°Å¸¦ À§ÇÑ NexoBridÀÇ ¹Ì±¹ ³» ½ÃÆÇ Çã°¡¸¦ ¹ßÇ¥Çß½À´Ï´Ù.
¶Ç ¹Ì±¹ ½ÄÇ°ÀǾ౹(FDA)Àº 2023³â 8¿ù, 2µµ È»óÀ» °ü¸®ÇÏ´Â Çõ½ÅÀûÀÎ ÅÂ¹Ý ¼¼Æ÷¿Ü ¸ÅÆ®¸¯½º ÀÇ·á±â±â¸¦ ½ÂÀÎÇß½À´Ï´Ù.
¾ïÁ¦¿äÀÎ
³ôÀº Ä¡·á ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·, È»ó Ä¡·á ¼¾ÅÍÀÇ Á¦ÇÑµÈ °¡¿ë¼º, °í±Þ Ä¡·á ¹× ±â¼ú¿¡ ´ëÇÑ Á¦ÇÑµÈ Á¢±Ù¼º, È»ó ¿¹¹æ¿¡ ´ëÇÑ °³ÀÎÀÇ Á¦ÇÑµÈ ÀÎ½Ä µîÀÇ ¿äÀÎÀÌ ½ÃÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Overview
The global burn care market reached US$ 2.53 billion in 2023 and is expected to reach US$ 4.43 billion by 2031, growing at a CAGR of 7.4% during the forecast period 2024-2031.
A burn is an injury to the skin or other organic tissue primarily caused by heat or due to radiation, radioactivity, electricity, friction, or contact with chemicals.
Burns are skin injuries involving two layers the thin outer epidermis and the thicker, deeper dermis. 86% of burns are caused by thermal injury, while about 4% are electrical and 3% are chemical.
The market is driven by factors such as the rising incidence of burn injuries, rising awareness about treatment & technological advancements, and rising demand for skin grafts.
Market Dynamics
Drivers
Rising Incidence of Burn Injuries
The demand for the global burn care market is driven by multiple factors. Burns are among the leading causes of disability-adjusted life-years (DALYs) lost in low- and middle-income countries.
According to WHO statistics in October 2023, in India, over 1 million people are moderately or severely burnt every year. Nearly 173,000 Bangladeshi children are moderately or severely burnt every year. In Bangladesh, Colombia, Egypt, and Pakistan, 17% of children with burns have a temporary disability and 18% have a permanent disability.
In addition, major player's strategies such as partnerships and collaborations, government initiatives, new product launches, and approvals would drive this market growth.
For instance, in June 2023, the Rotary Club, in collaboration with Aster MIMS, Calicut, launched North Kerala's first Skin Bank. This groundbreaking initiative aims to address the critical need for skin grafting in burn patients and significantly improve their chances of recovery.
Also, in February 2024, the NABICON conference in Ranchi discusses advancements in burn management, aiming to enhance awareness and treatment.
Similarly, in September 2023, Vericel Corporation announced the U.S. commercial availability of NexoBrid for the removal of eschar in adults with deep partial- and/or full-thickness thermal burns.
Also, in August 2023, the US Food and Drug Administration (FDA) cleared an innovative placental extracellular matrix medical device to manage second-degree burns the first of its kind.
Restraints
Factors such as the high treatment costs, stringent regulatory requirements, lack of skilled professionals, limited availability of burn care centers, limited access to advanced treatments and technologies, and limited awareness about burn prevention among individuals are expected to hamper the market.
For more details on this report - Request for Sample
The global burn care market is segmented based on burn type, depth of burn, product type, end-user, and region.
The advanced dressing segment accounted for approximately 54.4% of the global burn care market share
The advanced dressing segment is expected to hold the largest market share over the forecast period. Advanced dressings include collagen, alginate, hydrocolloid, hydrogel dressings, foam, and film dressings, as well as other advanced dressing products. These dressings offer advanced wound management solutions, promoting a moist wound environment and facilitating efficient healing.
Moreover, key players introducing new product launches in the treatment are expected to drive this segment growth. For instance, in January 2023, Convatec announced the US launch of ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.
Similarly, in April 2023, Medtronic introduced the release of its new burn care dressing, the Medtronic Mepilex Border Lite Burn Dressing. The dressing is designed to provide moist and healing surroundings for burns, while additionally protecting the wound from infection.
Also, in June 2022, Medline launched the Optifoam Gentle EX Foam Dressing to help reduce injuries. The product features five unique layers to help absorb shear force and friction and manage moisture.
North America accounted for approximately 41.2% of the global burn care market share
North America region is expected to hold the largest market share over the forecast period owing to the rising incidence of burn injuries in the U.S., would drive this market growth.
According to a BCEN news release in October 2023, in the U.S., over 400,000 seek medical treatment for burn injuries annually, with 40,000 hospitalizations, including 30,000 at hospital burn centers, and over 3,800 deaths. Worldwide, there are approximately 11 million burn cases and 180,000 deaths annually.
Moreover, in this region, key player's strategies such as partnerships & collaboration and advanced healthcare systems propel this market growth. For instance, in March 2022, Convatec Group Plc announced that it had completed the acquisition of Triad Life Sciences Inc ('Triad'). The Triad team's current portfolio and product pipeline will transition to Convatec's Advanced Wound Care (AWC) business and become known as Convatec Advanced Tissue Technologies.
The acquisition supports Convatec's FISBE strategy by strengthening Convatec's AWC position in the US and securing access to a complementary and innovative technology platform that enhances advanced wound management and patient outcomes.
Similarly, in November 2023, MetroHealth's nationally recognized Comprehensive Burn Care Center was reverified as an adult and pediatric burn center by the American Burn Association.
The major global players in the burn care market include 3M, Cardinal Health, Integra LifeSciences, Coloplast Corp, DeRoyal Industries, Smith & Nephew, ConvaTec Inc, Johnson & Johnson, B. Braun Medical Ltd, and Medline Industries among others.
The global burn care market report would provide approximately 70 tables, 81 figures, and 183 Pages.
Target Audience 2024
LIST NOT EXHAUSTIVE